Skip to main content
SpringerLink
Log in

Epidemiology of Pediatric Pulmonary Hypertension

  • Reference work entry
  • First Online:
Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care

Abstract

Pulmonary hypertension (PH) is a rare condition. Data on adult PH patients is abundant, but data on pediatric PH are scarce. Nevertheless, in the past decade, increasing data concerning pediatric PH are becoming available, enabling this review of the epidemiology, characterization, and outcome of pediatric pulmonary hypertension.

PH is a condition that is associated with a variety of diseases. It is a rare condition in children with a complex and age-specific presentation. Transient forms of pulmonary arterial hypertension (PAH), i.e., potentially reversible PAH, specifically occur in children and form the largest group of pediatric PH. Advanced PAH in children is predominantly idiopathic or associated with congenital heart disease. Other forms of PAH seldom occur in children. WHO PH groups 2–5 are rare in childhood; however, they may be underreported.

The clinical presentation of pediatric PH is relatively nonspecific as it is in adults, with dyspnea on exertion as the most common presenting symptom. However, the clinical presentation of pediatric PH includes symptoms specific for children such as syncope. Pediatric PH frequently co-occurs with genetic and syndromal abnormalities, including Down syndrome. Right heart failure is less common in children despite a severe hemodynamic profile.

PAH is a detrimental disease with a poor prognosis. Outcome of pediatric PAH differs between patients with different types of congenital heart disease. In the last decades, new PAH-targeted therapies have been developed, which have improved outcome in pediatric pulmonary arterial hypertension. However, currently reported survival rates vary and critical appraisal of patient populations, survival data, and proposed treatment approaches is necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 1,299.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,799.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Authors/Task Force Members, Galie N, Hoeper MM et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30:2493–2537

    Google Scholar 

  2. van Loon RL, Roofthooft MT, Hillege HL et al (2011) Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005. Circulation 124:1755–1764

    Article  PubMed  Google Scholar 

  3. Fishman AP (1998) Etiology and pathogenesis of primary pulmonary hypertension: a perspective. Chest 114:242S–247S

    Article  CAS  PubMed  Google Scholar 

  4. Simonneau G, Galie N, Rubin LJ et al (2004) Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43:5S–12S

    Article  PubMed  Google Scholar 

  5. Simonneau G, Robbins IM, Beghetti M et al (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54:S43–S54

    Article  PubMed  Google Scholar 

  6. Barst RJ, Ertel SI, Beghetti M et al (2011) Pulmonary arterial hypertension: a comparison between children and adults. Eur Respir J 37:665–677

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Rosenzweig EB, Widlitz AC, Barst RJ (2004) Pulmonary arterial hypertension in children. Pediatr Pulmonol 38:2–22

    Article  PubMed  Google Scholar 

  8. van Loon RL, Roofthooft MT, Osch-Gevers M et al (2009) Clinical characterization of pediatric pulmonary hypertension: complex presentation and diagnosis. J Pediatr 155:176–182

    Article  PubMed  Google Scholar 

  9. Humbert M, Morrell NW, Archer SL et al (2004) Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43:13S–24S

    Article  CAS  PubMed  Google Scholar 

  10. Jeffery TK, Morrell NW (2002) Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. Prog Cardiovasc Dis 45:173–202

    Article  CAS  PubMed  Google Scholar 

  11. Pietra GG, Capron F, Stewart S et al (2004) Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 43:25S–32S

    Article  PubMed  Google Scholar 

  12. Harrison RE, Berger R, Haworth SG et al (2005) Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood. Circulation 111:435–441

    Article  CAS  PubMed  Google Scholar 

  13. Nasim MT, Ogo T, Ahmed M et al (2011) Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension. Hum Mutat 32:1385–1389

    Article  CAS  PubMed  Google Scholar 

  14. Austin ED, Ma L, Leduc C et al (2012) Whole exome sequencing to identify a novel gene (Caveolin-1) associated with human pulmonary arterial hypertension. Circ Cardiovasc Genet 5(3):336–343

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Rosenzweig EB, Morse JH, Knowles JA et al (2008) Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension. J Heart Lung Transplant 27:668–674

    Article  PubMed  Google Scholar 

  16. Schulze-Neick I, Beghetti M (2008) Classifying pulmonary hypertension in the setting of the congenitally malformed heart–cleaning up a dog’s dinner. Cardiol Young 18:22–25

    Article  PubMed  Google Scholar 

  17. Berger RM, Beghetti M, Humpl T et al (2012) Clinical features of paediatric pulmonary hypertension: a registry study. Lancet 379:537–546

    Article  PubMed  PubMed Central  Google Scholar 

  18. Berner M, Beghetti M, Spahr-Schopfer I et al (1996) Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease. Am J Cardiol 77:532–535

    Article  CAS  PubMed  Google Scholar 

  19. Berger RM (2000) Possibilities and impossibilities in the evaluation of pulmonary vascular disease in congenital heart defects. Eur Heart J 21:17–27

    Article  CAS  PubMed  Google Scholar 

  20. van Loon RL, Roofthooft MT, Berger RM (2009) Pulmonary arterial hypertension in children with congenital heart disease. PVRI Rev 1:219–223

    Google Scholar 

  21. Andrews R, Tulloh R, Magee A et al (2002) Atrial septal defect with failure to thrive in infancy: hidden pulmonary vascular disease? Pediatr Cardiol 23:528–530

    Article  PubMed  Google Scholar 

  22. Tulloh RM (2005) Congenital heart disease in relation to pulmonary hypertension in paediatric practice. Paediatr Respir Rev 6:174–180

    Article  PubMed  Google Scholar 

  23. Ivy DD, Feinstein JA, Humpl T et al (2009) Non-congenital heart disease associated pediatric pulmonary arterial hypertension. Prog Paediatr Cardiol 27:13–23

    Article  CAS  Google Scholar 

  24. Stayer SA, Liu Y (2010) Pulmonary hypertension of the newborn. Best Pract Res Clin Anaesthesiol 24:375–386

    Article  PubMed  Google Scholar 

  25. Roofthooft MT, Elema A, Bergman KA et al (2011) Patient characteristics in persistent pulmonary hypertension of the newborn. Pulm Med 2011:858154

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Duffels MG, Engelfriet PM, Berger RM et al (2007) Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J Cardiol 120:198–204

    Article  CAS  PubMed  Google Scholar 

  27. Stenmark KR, Abman SH (2005) Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu Rev Physiol 67:623–661

    Article  CAS  PubMed  Google Scholar 

  28. Carmosino MJ, Friesen RH, Doran A et al (2007) Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization. Anesth Analg 104:521–527

    Article  PubMed  PubMed Central  Google Scholar 

  29. Humbert M, Sitbon O, Chaouat A et al (2006) Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 173:1023–1030

    Article  PubMed  Google Scholar 

  30. Peacock AJ, Murphy NF, McMurray JJ et al (2007) An epidemiological study of pulmonary arterial hypertension. Eur Respir J 30:104–109

    Article  CAS  PubMed  Google Scholar 

  31. Moledina S, Hislop AA, Foster H et al (2010) Childhood idiopathic pulmonary arterial hypertension: a national cohort study. Heart 96:1401–1406

    Article  CAS  PubMed  Google Scholar 

  32. Fraisse A, Jais X, Schleich JM et al (2010) Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France. Arch Cardiovasc Dis 103:66–74

    Article  PubMed  Google Scholar 

  33. Barst RJ, McGoon MD, Elliott CG et al (2012) Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Circulation 125:113–122

    Article  PubMed  Google Scholar 

  34. Walsh-Sukys MC, Tyson JE, Wright LL et al (2000) Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 105:14–20

    Article  CAS  PubMed  Google Scholar 

  35. Khemani E, McElhinney DB, Rhein L et al (2007) Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 120:1260–1269

    Article  PubMed  Google Scholar 

  36. Rich S, Dantzker DR, Ayres SM et al (1987) Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107:216–223

    Article  CAS  PubMed  Google Scholar 

  37. Le RJ, Fenstad ER, Maradit-Kremers H et al (2011) Syncope in adults with pulmonary arterial hypertension. J Am Coll Cardiol 58:863–867

    Article  PubMed  Google Scholar 

  38. Badesch DB, Raskob GE, Elliott CG et al (2010) Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry. Chest 137:376–387

    Article  PubMed  Google Scholar 

  39. Barst RJ, Maislin G, Fishman AP (1999) Vasodilator therapy for primary pulmonary hypertension in children. Circulation 99:1197–1208

    Article  CAS  PubMed  Google Scholar 

  40. Barst RJ (1986) Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension. Chest 89:497–503

    Article  CAS  PubMed  Google Scholar 

  41. Sitbon O, Humbert M, Jais X et al (2005) Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 111:3105–3111

    Article  CAS  PubMed  Google Scholar 

  42. Douwes JM, van Loon RL, Hoendermis ES et al (2011) Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria. Eur Heart J 32:3137–3146

    Article  PubMed  Google Scholar 

  43. van Albada ME, Berger RM (2008) Pulmonary arterial hypertension in congenital cardiac disease–the need for refinement of the Evian-Venice classification. Cardiol Young 18:10–17

    PubMed  Google Scholar 

  44. Cerro MJ, Abman S, Diaz G et al (2011) A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: report from the PVRI Pediatric Taskforce, Panama 2011. Pulm Circ 1:286–298

    Article  PubMed  PubMed Central  Google Scholar 

  45. D’Alonzo GE, Barst RJ, Ayres SM et al (1991) Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115:343–349

    Article  PubMed  Google Scholar 

  46. van Loon RL, Roofthooft MT, Delhaas T et al (2010) Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies. Am J Cardiol 106:117–124

    Article  PubMed  Google Scholar 

  47. Ivy DD, Rosenzweig EB, Lemarie JC et al (2010) Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings. Am J Cardiol 106:1332–1338

    Article  PubMed  PubMed Central  Google Scholar 

  48. Haworth SG, Hislop AA (2009) Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001–2006. Heart 95:312–317

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Congenital Heart Diseases, Department of Pediatric Cardiology, Beatrix Children’s Hospital, University Medical Center Groningen, University of Groningen, 30.001, Groningen, The Netherlands

    Johannes M. Douwes & Rolf M. F. Berger

Authors
  1. Johannes M. Douwes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rolf M. F. Berger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Johannes M. Douwes .

Editor information

Editors and Affiliations

  1. Dept. of Pediatric Cardiology, Children's Hospital Colorado, Univ. of Colorado, Denver, Aurora, Colorado, USA

    Eduardo M. Da Cruz

  2. Dept. Pediatric Cardiology, Children's Hospital Colorado, Univ. of Colorado, Denver, Aurora, Colorado, USA

    Dunbar Ivy

  3. Pediatric Cardiac Surgery, Children's Hospital Colorado, Univ. of Colorado, Denver, Aurora, Colorado, USA

    James Jaggers

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this entry

Cite this entry

Douwes, J.M., Berger, R.M.F. (2014). Epidemiology of Pediatric Pulmonary Hypertension. In: Da Cruz, E., Ivy, D., Jaggers, J. (eds) Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care. Springer, London. https://doi.org/10.1007/978-1-4471-4619-3_204

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4619-3_204

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4618-6

  • Online ISBN: 978-1-4471-4619-3

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation